Magnetic resonance imaging (MRI)-based volumetric measurements of medial temporal
lobe (MTL) structures can discriminate between normal elderly control subjects and patients …

Background Early pathological involvement of specific medial temporal lobe areas is
characteristic for Alzheimer's disease (AD). Objective To determine the extent of regional …

Background: Despite convenience, accessibility, and strong correlation to severity of
Alzheimer disease (AD) pathology, medial temporal lobe atrophy (MTA) has not been used …

Magnetic resonance imaging (MRI) has shown a great reduction in medial temporal lobe
and hippocampal volume of patients with Alzheimer's disease as compared to controls …

Background: Medial temporal lobe atrophy (MTA) is a sensitive radiologic marker for
Alzheimer disease (AD) and associated with cognitive impairment. The value of MTA in the …

OBJECTIVES It has been shown that atrophy of medial temporal lobe structures such as the
hippocampus and entorhinal cortex shown on MRI may distinguish patients with Alzheimer's …

Memory impairment and medial temporal lobe (MTL) involvement are the earliest and most
prominent features of Alzheimer's disease (AD). A psychological assessment of memory …

BACKGROUND AND PURPOSE: Mild cognitive impairment (MCI) represents a transitional
state between normal aging and Alzheimer disease (AD). Our goal was to determine if …

Background: The clinical diagnosis of Alzheimer's disease (AD) can be difficult to make in
early stages of disease. Structural neuroimaging offers a potential tool in the clinical …

To determine whether the medial temporal lobe is atrophic in subjects with mild cognitive
impairment, and whether atrophy of this structure is a better predictor of dementia than …